Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REMEX: Remifentanil concentrations for cough during extubation
NCT02711904Phase 4Completed
- Start
- Jan 2011
- Primary completion
- Jan 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of remifentanil in cough (2 arms). Primary endpoint: Frequency and Intensity of Coughing. Started Jan 2011; status: completed.
02
Drugs
remifentanil
03
Conditions
cough
Beyond the preview
Go deeper on NCT02711904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02711904.